跳至主要内容
临床试验/DRKS00027419
DRKS00027419已完成未知

The SPOT C-MIC Follow-up Study - SPOT F

Berlin Heals GmbH0 个研究点目标入组 7 人开始时间: 2021年12月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
7

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • Patients from the per protocol treatment group who have received a C-MIC System during the SPOT C-MIC Study.
  • Informed consent in writing from the patient

排除标准

  • Patients who are unwilling or unable to participate in the study visits.

研究者

相似试验

已完成
不适用
Post-Market Clinical Follow-up study (PMCF) for confirmation of the performance and safety of Fructaid®E74.3Other disorders of intestinal carbohydrate absorption
DRKS00021586Vitacare GmbH & Co. KG48
进行中(未招募)
3 期
A post-market clinical follow-up study of Perfectha Subskin LidocaineA range of Fitzpatrick skin types presenting significant loss of volume in the cheeks, jawline and/or chinSkin and Connective Tissue Diseases
ISRCTN63865080Sinclair Pharma69
进行中(未招募)
不适用
Study of a new drug combination to treat Chronic Lymphocytic Leukemiantreated or Relapsed Chronic Lymphocytic LeukaemiaMedDRA version: 14.1Level: LLTClassification code 10008968Term: Chronic lymphocytic leukaemia stage A(0)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2011-005178-43-ITGLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.80
已完成
不适用
Post-market clinical follow-up (PMCF) study to observe the course of symptoms of vulvovaginal dryness in patients receiving therapy with KadeFungin® BefeuchtungsgelN89.8Other specified noninflammatory disorders of vagina
DRKS00017248DR. KADE Pharmazeutische Fabrik GmbH100
已完成
不适用
Post-Market Clinical Follow-up (PMCF) Study with the MOBIS II ST cage-implant for transforaminal lumbar fusion (TLIF)Diseases of the lumbar spine (L1-S1) like degenerative disc diseases, mechanical instability and osteochondrosis.M42.16M43.16M43.17M47.26M48.06M51.2M51.3M53.26M47.17Other specified intervertebral disc displacementOther specified intervertebral disc degeneration
DRKS00020523SIGNUS Medizintechnik GmbH57